Search results for "molecular microbiology"

CN Bio supports R&D efforts via fast-track Drug Metabolism and Safety Toxicity Testing Services that deliver human translatable insights from lead candidates in a few weeks and at lower cost than animal studies. By accessing the Company’s expertise and advanced in vitro liver-on-chip models, these Services enable researchers to step beyond standard in-house laboratory workflows for better informed pre-clinical decisions.

High Quality Assays with Reproducible and Reliable Results

High Quality Assays with Reproducible and Reliable Results

High Quality Assays with Reproducible and Reliable Results

Patients with underlying heart problems are more than four times as likely to die from COVID-19

Guest editorial: Brice Ezzouaouy, Senior Product Manager, Beckman Coulter Life Sciences, outlines the challenges of dimly expressed markers and presents a solution

Novel column technology designed to put disease research and drug development on a more productive and efficient path

From CRISPR screening in primary T cells to photodynamic therapy for curing cancer, we take a look back at research highlights and emerging technologies from the past year

Next-generation biobanking and cell culture technology for pathophysiologically relevant in vitro tumor models

This guest editorial from SPT Labtech introduces the Labtech Unplugged podcast series, sharing real-world stories of labs worldwide implementing sustainable practices

AMSBIO has developed and optimized methods and tools for fast, scalable and reproducible Extracellular Vesicle (EV) purification, as well as addressing EV heterogeneity and high throughput solutions for biomarker discovery.

The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2

A new cfPure Max kit from AMSBIO is now available for use on samples of 5mLs volume or greater